- Home
- VITL vs MDXG Comparison
VITL vs MDXG Comparison
Compare VITL & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VITL
- MDXG
- Stock Information
- Founded
- VITL 2007
- MDXG 2006
- Country
- VITL United States
- MDXG United States
- Employees
- VITL N/A
- MDXG N/A
- Industry
- VITL Packaged Foods
- MDXG Biotechnology: Pharmaceutical Preparations
- Sector
- VITL Consumer Staples
- MDXG Health Care
- Exchange
- VITL Nasdaq
- MDXG Nasdaq
- Market Cap
- VITL 1.5B
- MDXG 1.3B
- IPO Year
- VITL 2020
- MDXG N/A
- Fundamental
- Price
- VITL $34.90
- MDXG $7.98
- Analyst Decision
- VITL Strong Buy
- MDXG Strong Buy
- Analyst Count
- VITL 9
- MDXG 5
- Target Price
- VITL $41.25
- MDXG $12.00
- AVG Volume (30 Days)
- VITL 1.1M
- MDXG 518.6K
- Earning Date
- VITL 02-27-2025
- MDXG 02-26-2025
- Dividend Yield
- VITL N/A
- MDXG N/A
- EPS Growth
- VITL 151.76
- MDXG N/A
- EPS
- VITL 1.12
- MDXG 0.52
- Revenue
- VITL $576,129,000.00
- MDXG $342,804,000.00
- Revenue This Year
- VITL $29.83
- MDXG $9.56
- Revenue Next Year
- VITL $18.59
- MDXG $9.19
- P/E Ratio
- VITL $31.05
- MDXG $15.86
- Revenue Growth
- VITL 29.14
- MDXG 10.93
- 52 Week Low
- VITL $16.18
- MDXG $5.47
- 52 Week High
- VITL $48.41
- MDXG $10.14
- Technical
- Relative Strength Index (RSI)
- VITL 37.11
- MDXG 35.32
- Support Level
- VITL $33.14
- MDXG $7.81
- Resistance Level
- VITL $36.60
- MDXG $8.54
- Average True Range (ATR)
- VITL 1.81
- MDXG 0.23
- MACD
- VITL -0.44
- MDXG -0.05
- Stochastic Oscillator
- VITL 20.18
- MDXG 18.09
About VITL Vital Farms Inc.
Vital Farms Inc is an ethical food company. The company retails pasture-raised eggs and butter. Its products include Pasture-Raised Eggs and Pasture-Raised Butter & Ghee. The company's purpose is rooted in a commitment to Conscious Capitalism, which prioritizes the long-term benefits of its stakeholders (farmers and suppliers, customers and consumers, communities and the environment, employees, and stockholders).
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.